Companies in the Technology sector have received a lot of coverage today as analysts weigh in on POET Technologies (POET – Research Report) and GoodRx Holdings (GDRX – Research Report).
POET Technologies (POET)
H.C. Wainwright analyst Kevin Dede reiterated a Buy rating on POET Technologies today and set a price target of $5.00. The company’s shares closed last Tuesday at $3.71.
According to TipRanks.com, Dede has 0 stars on 0-5 stars ranking scale with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for POET Technologies with a $5.00 average price target.
See today’s best-performing stocks on TipRanks >>
GoodRx Holdings (GDRX)
In a report released today, Craig Hettenbach from Morgan Stanley maintained a Hold rating on GoodRx Holdings, with a price target of $6.00. The company’s shares closed last Tuesday at $5.49, close to its 52-week low of $3.82.
According to TipRanks.com, Hettenbach is a 5-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for GoodRx Holdings with a $7.04 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on POET:
- POET Technologies Introduces “POET Starlight” for the Artificial Intelligence Market and Receives Advanced Purchase Order from Celestial AI
- POET Technologies Expands Investor Outreach Efforts
- POET Technologies Reports Fourth Quarter 2022 Financial Results
- Poet Technologies reports Q4 EPS (17c) vs. (10c) last year
- Poet Technologies reports no exposure to Silicon Valley Bank
